Oxford Biomedica Plc Stock Shares Outstanding
| OXBDF Stock | USD 2.72 0.10 3.82% |
Oxford Biomedica plc fundamentals help investors to digest information that contributes to Oxford Biomedica's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Biomedica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Biomedica pink sheet.
Oxford |
Oxford Biomedica plc Company Shares Outstanding Analysis
Oxford Biomedica's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Oxford Biomedica Shares Outstanding | 96.27 M |
Most of Oxford Biomedica's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Biomedica plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Oxford Biomedica plc has 96.27 M of shares currently outstending. This is 46.67% lower than that of the Healthcare sector and 9.9% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 83.16% higher than that of the company.
Oxford Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Biomedica's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Biomedica could also be used in its relative valuation, which is a method of valuing Oxford Biomedica by comparing valuation metrics of similar companies.Oxford Biomedica is currently under evaluation in shares outstanding category among related companies.
Oxford Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | -0.024 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 436.12 M | |||
| Shares Outstanding | 96.27 M | |||
| Shares Owned By Insiders | 6.19 % | |||
| Shares Owned By Institutions | 62.89 % | |||
| Price To Earning | 17.67 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 3.60 X | |||
| Revenue | 142.8 M | |||
| Gross Profit | 82.64 M | |||
| EBITDA | 33.22 M | |||
| Net Income | 19.01 M | |||
| Cash And Equivalents | 118.55 M | |||
| Cash Per Share | 1.23 X | |||
| Total Debt | 107.5 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 2.31 X | |||
| Cash Flow From Operations | 25.45 M | |||
| Earnings Per Share | 0.24 X | |||
| Number Of Employees | 959 | |||
| Beta | 0.97 | |||
| Market Capitalization | 548.76 M | |||
| Total Asset | 237.23 M | |||
| Working Capital | 12.54 M | |||
| Current Asset | 25.71 M | |||
| Current Liabilities | 13.17 M | |||
| Z Score | 3.0 | |||
| Net Asset | 237.23 M |
About Oxford Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Biomedica plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Biomedica plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oxford Biomedica plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Oxford Biomedica plc information on this page should be used as a complementary analysis to other Oxford Biomedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Oxford Pink Sheet analysis
When running Oxford Biomedica's price analysis, check to measure Oxford Biomedica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedica is operating at the current time. Most of Oxford Biomedica's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford Biomedica's price. Additionally, you may evaluate how the addition of Oxford Biomedica to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |